
Levy explains elafibranor’s role in the PBC 2LT treatment landscape and new long-term ELATIVE open-label extension data presented at AASLD 2025.

Cynthia Levy, MD, is a professor of clinical medicine and hepatology at the University of Miami Miller School of Medicine.